nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—EPHB1—tongue—larynx cancer	0.0465	0.0465	CbGeAlD
Dasatinib—EPHB1—mouth—larynx cancer	0.0313	0.0313	CbGeAlD
Dasatinib—PKMYT1—neck—larynx cancer	0.023	0.023	CbGeAlD
Dasatinib—EPHA4—tongue—larynx cancer	0.021	0.021	CbGeAlD
Dasatinib—ERBB3—exocrine gland—larynx cancer	0.0187	0.0187	CbGeAlD
Dasatinib—LIMK2—mouth—larynx cancer	0.0164	0.0164	CbGeAlD
Dasatinib—TEC—thyroid gland—larynx cancer	0.0162	0.0162	CbGeAlD
Dasatinib—BMX—epithelium—larynx cancer	0.0153	0.0153	CbGeAlD
Dasatinib—SIK1—mouth—larynx cancer	0.0143	0.0143	CbGeAlD
Dasatinib—EPHA4—mouth—larynx cancer	0.0142	0.0142	CbGeAlD
Dasatinib—ERBB3—mouth—larynx cancer	0.014	0.014	CbGeAlD
Dasatinib—STAT5B—epithelium—larynx cancer	0.0136	0.0136	CbGeAlD
Dasatinib—MAPK14—mouth—larynx cancer	0.013	0.013	CbGeAlD
Dasatinib—EPHB1—thyroid gland—larynx cancer	0.0127	0.0127	CbGeAlD
Dasatinib—PTK6—trachea—larynx cancer	0.0127	0.0127	CbGeAlD
Dasatinib—KIT—exocrine gland—larynx cancer	0.0115	0.0115	CbGeAlD
Dasatinib—MAPK14—neck—larynx cancer	0.0112	0.0112	CbGeAlD
Dasatinib—PKMYT1—thyroid gland—larynx cancer	0.011	0.011	CbGeAlD
Dasatinib—BMPR1B—epithelium—larynx cancer	0.0109	0.0109	CbGeAlD
Dasatinib—BMX—thyroid gland—larynx cancer	0.0107	0.0107	CbGeAlD
Dasatinib—TEC—lymph node—larynx cancer	0.0101	0.0101	CbGeAlD
Dasatinib—STAT5B—thyroid gland—larynx cancer	0.00948	0.00948	CbGeAlD
Dasatinib—TESK1—trachea—larynx cancer	0.00886	0.00886	CbGeAlD
Dasatinib—EPHA3—thyroid gland—larynx cancer	0.00876	0.00876	CbGeAlD
Dasatinib—STK36—trachea—larynx cancer	0.00872	0.00872	CbGeAlD
Dasatinib—EPHB3—trachea—larynx cancer	0.00872	0.00872	CbGeAlD
Dasatinib—KIT—mouth—larynx cancer	0.00857	0.00857	CbGeAlD
Dasatinib—SIK3—thyroid gland—larynx cancer	0.00853	0.00853	CbGeAlD
Dasatinib—RIPK2—epithelium—larynx cancer	0.00852	0.00852	CbGeAlD
Dasatinib—LIMK2—trachea—larynx cancer	0.00843	0.00843	CbGeAlD
Dasatinib—ERBB3—epithelium—larynx cancer	0.00815	0.00815	CbGeAlD
Dasatinib—CSK—trachea—larynx cancer	0.00811	0.00811	CbGeAlD
Dasatinib—HCK—trachea—larynx cancer	0.00801	0.00801	CbGeAlD
Dasatinib—ZAK—thyroid gland—larynx cancer	0.00793	0.00793	CbGeAlD
Dasatinib—EPHB1—lymph node—larynx cancer	0.00791	0.00791	CbGeAlD
Dasatinib—BMPR1B—thyroid gland—larynx cancer	0.0076	0.0076	CbGeAlD
Dasatinib—MAPK14—epithelium—larynx cancer	0.00759	0.00759	CbGeAlD
Dasatinib—BTK—thyroid gland—larynx cancer	0.00756	0.00756	CbGeAlD
Dasatinib—RIPK2—trachea—larynx cancer	0.00753	0.00753	CbGeAlD
Dasatinib—TNK2—thyroid gland—larynx cancer	0.00745	0.00745	CbGeAlD
Dasatinib—KIT—neck—larynx cancer	0.00733	0.00733	CbGeAlD
Dasatinib—EPHA4—trachea—larynx cancer	0.00728	0.00728	CbGeAlD
Dasatinib—ERBB3—trachea—larynx cancer	0.00721	0.00721	CbGeAlD
Dasatinib—EPHB4—epithelium—larynx cancer	0.0072	0.0072	CbGeAlD
Dasatinib—PDGFRB—neck—larynx cancer	0.00716	0.00716	CbGeAlD
Dasatinib—JAK2—epithelium—larynx cancer	0.00714	0.00714	CbGeAlD
Dasatinib—EPHA2—epithelium—larynx cancer	0.00706	0.00706	CbGeAlD
Dasatinib—TESK1—thyroid gland—larynx cancer	0.00701	0.00701	CbGeAlD
Dasatinib—STK36—thyroid gland—larynx cancer	0.0069	0.0069	CbGeAlD
Dasatinib—LCK—trachea—larynx cancer	0.00668	0.00668	CbGeAlD
Dasatinib—LIMK2—thyroid gland—larynx cancer	0.00667	0.00667	CbGeAlD
Dasatinib—BMX—lymph node—larynx cancer	0.00665	0.00665	CbGeAlD
Dasatinib—BLK—lymph node—larynx cancer	0.00657	0.00657	CbGeAlD
Dasatinib—STK35—thyroid gland—larynx cancer	0.00646	0.00646	CbGeAlD
Dasatinib—CSK—thyroid gland—larynx cancer	0.00642	0.00642	CbGeAlD
Dasatinib—EPHB4—trachea—larynx cancer	0.00636	0.00636	CbGeAlD
Dasatinib—HCK—thyroid gland—larynx cancer	0.00634	0.00634	CbGeAlD
Dasatinib—JAK2—trachea—larynx cancer	0.00632	0.00632	CbGeAlD
Dasatinib—ABL2—thyroid gland—larynx cancer	0.0063	0.0063	CbGeAlD
Dasatinib—TXK—lymph node—larynx cancer	0.00629	0.00629	CbGeAlD
Dasatinib—EPHA2—trachea—larynx cancer	0.00624	0.00624	CbGeAlD
Dasatinib—FYN—trachea—larynx cancer	0.00623	0.00623	CbGeAlD
Dasatinib—SRC—epithelium—larynx cancer	0.00612	0.00612	CbGeAlD
Dasatinib—MAP4K5—trachea—larynx cancer	0.00609	0.00609	CbGeAlD
Dasatinib—MAP3K3—trachea—larynx cancer	0.00609	0.00609	CbGeAlD
Dasatinib—RIPK2—thyroid gland—larynx cancer	0.00596	0.00596	CbGeAlD
Dasatinib—STAT5B—lymph node—larynx cancer	0.00589	0.00589	CbGeAlD
Dasatinib—EPHB6—trachea—larynx cancer	0.00582	0.00582	CbGeAlD
Dasatinib—SIK1—thyroid gland—larynx cancer	0.00582	0.00582	CbGeAlD
Dasatinib—EPHA4—thyroid gland—larynx cancer	0.00576	0.00576	CbGeAlD
Dasatinib—ERBB3—thyroid gland—larynx cancer	0.0057	0.0057	CbGeAlD
Dasatinib—MAP3K2—thyroid gland—larynx cancer	0.00565	0.00565	CbGeAlD
Dasatinib—YES1—trachea—larynx cancer	0.00562	0.00562	CbGeAlD
Dasatinib—PDGFRA—trachea—larynx cancer	0.00552	0.00552	CbGeAlD
Dasatinib—EPHA3—lymph node—larynx cancer	0.00544	0.00544	CbGeAlD
Dasatinib—MAPK14—thyroid gland—larynx cancer	0.00531	0.00531	CbGeAlD
Dasatinib—SIK3—lymph node—larynx cancer	0.0053	0.0053	CbGeAlD
Dasatinib—FGR—thyroid gland—larynx cancer	0.00529	0.00529	CbGeAlD
Dasatinib—LCK—thyroid gland—larynx cancer	0.00529	0.00529	CbGeAlD
Dasatinib—FMO3—thyroid gland—larynx cancer	0.00511	0.00511	CbGeAlD
Dasatinib—EPHB4—thyroid gland—larynx cancer	0.00503	0.00503	CbGeAlD
Dasatinib—JAK2—thyroid gland—larynx cancer	0.005	0.005	CbGeAlD
Dasatinib—KIT—epithelium—larynx cancer	0.00499	0.00499	CbGeAlD
Dasatinib—MAP2K5—trachea—larynx cancer	0.00498	0.00498	CbGeAlD
Dasatinib—EPHA2—thyroid gland—larynx cancer	0.00494	0.00494	CbGeAlD
Dasatinib—FYN—thyroid gland—larynx cancer	0.00493	0.00493	CbGeAlD
Dasatinib—ZAK—lymph node—larynx cancer	0.00492	0.00492	CbGeAlD
Dasatinib—PDGFRB—epithelium—larynx cancer	0.00487	0.00487	CbGeAlD
Dasatinib—CSF1R—trachea—larynx cancer	0.00486	0.00486	CbGeAlD
Dasatinib—MAP3K3—thyroid gland—larynx cancer	0.00482	0.00482	CbGeAlD
Dasatinib—MAP4K5—thyroid gland—larynx cancer	0.00482	0.00482	CbGeAlD
Dasatinib—BMPR1B—lymph node—larynx cancer	0.00472	0.00472	CbGeAlD
Dasatinib—BTK—lymph node—larynx cancer	0.0047	0.0047	CbGeAlD
Dasatinib—TNK2—lymph node—larynx cancer	0.00463	0.00463	CbGeAlD
Dasatinib—EPHB6—thyroid gland—larynx cancer	0.0046	0.0046	CbGeAlD
Dasatinib—CYP1A1—mouth—larynx cancer	0.00447	0.00447	CbGeAlD
Dasatinib—YES1—thyroid gland—larynx cancer	0.00445	0.00445	CbGeAlD
Dasatinib—KIT—trachea—larynx cancer	0.00441	0.00441	CbGeAlD
Dasatinib—PDGFRA—thyroid gland—larynx cancer	0.00436	0.00436	CbGeAlD
Dasatinib—TESK1—lymph node—larynx cancer	0.00435	0.00435	CbGeAlD
Dasatinib—PDGFRB—trachea—larynx cancer	0.00431	0.00431	CbGeAlD
Dasatinib—EPHB3—lymph node—larynx cancer	0.00428	0.00428	CbGeAlD
Dasatinib—STK36—lymph node—larynx cancer	0.00428	0.00428	CbGeAlD
Dasatinib—SRC—thyroid gland—larynx cancer	0.00428	0.00428	CbGeAlD
Dasatinib—LIMK2—lymph node—larynx cancer	0.00414	0.00414	CbGeAlD
Dasatinib—STK35—lymph node—larynx cancer	0.00401	0.00401	CbGeAlD
Dasatinib—CSK—lymph node—larynx cancer	0.00399	0.00399	CbGeAlD
Dasatinib—MAP2K5—thyroid gland—larynx cancer	0.00394	0.00394	CbGeAlD
Dasatinib—HCK—lymph node—larynx cancer	0.00394	0.00394	CbGeAlD
Dasatinib—ABL2—lymph node—larynx cancer	0.00391	0.00391	CbGeAlD
Dasatinib—CSF1R—thyroid gland—larynx cancer	0.00384	0.00384	CbGeAlD
Dasatinib—ABL1—trachea—larynx cancer	0.00384	0.00384	CbGeAlD
Dasatinib—RIPK2—lymph node—larynx cancer	0.0037	0.0037	CbGeAlD
Dasatinib—SIK1—lymph node—larynx cancer	0.00361	0.00361	CbGeAlD
Dasatinib—EPHA4—lymph node—larynx cancer	0.00358	0.00358	CbGeAlD
Dasatinib—ERBB3—lymph node—larynx cancer	0.00354	0.00354	CbGeAlD
Dasatinib—MAP3K2—lymph node—larynx cancer	0.00351	0.00351	CbGeAlD
Dasatinib—KIT—thyroid gland—larynx cancer	0.00349	0.00349	CbGeAlD
Dasatinib—PDGFRB—thyroid gland—larynx cancer	0.00341	0.00341	CbGeAlD
Dasatinib—MAPK14—lymph node—larynx cancer	0.0033	0.0033	CbGeAlD
Dasatinib—FGR—lymph node—larynx cancer	0.00329	0.00329	CbGeAlD
Dasatinib—LCK—lymph node—larynx cancer	0.00329	0.00329	CbGeAlD
Dasatinib—FMO3—lymph node—larynx cancer	0.00317	0.00317	CbGeAlD
Dasatinib—EPHB4—lymph node—larynx cancer	0.00313	0.00313	CbGeAlD
Dasatinib—JAK2—lymph node—larynx cancer	0.0031	0.0031	CbGeAlD
Dasatinib—EPHA2—lymph node—larynx cancer	0.00307	0.00307	CbGeAlD
Dasatinib—FYN—lymph node—larynx cancer	0.00306	0.00306	CbGeAlD
Dasatinib—ABL1—thyroid gland—larynx cancer	0.00304	0.00304	CbGeAlD
Dasatinib—MAP4K5—lymph node—larynx cancer	0.00299	0.00299	CbGeAlD
Dasatinib—MAP3K3—lymph node—larynx cancer	0.00299	0.00299	CbGeAlD
Dasatinib—EPHB6—lymph node—larynx cancer	0.00286	0.00286	CbGeAlD
Dasatinib—YES1—lymph node—larynx cancer	0.00276	0.00276	CbGeAlD
Dasatinib—PDGFRA—lymph node—larynx cancer	0.00271	0.00271	CbGeAlD
Dasatinib—SRC—lymph node—larynx cancer	0.00266	0.00266	CbGeAlD
Dasatinib—CYP1A1—epithelium—larynx cancer	0.0026	0.0026	CbGeAlD
Dasatinib—CYP1B1—thyroid gland—larynx cancer	0.00257	0.00257	CbGeAlD
Dasatinib—MAP2K5—lymph node—larynx cancer	0.00245	0.00245	CbGeAlD
Dasatinib—CSF1R—lymph node—larynx cancer	0.00239	0.00239	CbGeAlD
Dasatinib—CYP1A1—trachea—larynx cancer	0.0023	0.0023	CbGeAlD
Dasatinib—KIT—lymph node—larynx cancer	0.00217	0.00217	CbGeAlD
Dasatinib—PDGFRB—lymph node—larynx cancer	0.00212	0.00212	CbGeAlD
Dasatinib—ABCG2—thyroid gland—larynx cancer	0.00192	0.00192	CbGeAlD
Dasatinib—ABL1—lymph node—larynx cancer	0.00189	0.00189	CbGeAlD
Dasatinib—CYP1A2—thyroid gland—larynx cancer	0.00184	0.00184	CbGeAlD
Dasatinib—CYP1A1—thyroid gland—larynx cancer	0.00182	0.00182	CbGeAlD
Dasatinib—CYP1B1—lymph node—larynx cancer	0.0016	0.0016	CbGeAlD
Dasatinib—ABCB1—epithelium—larynx cancer	0.00135	0.00135	CbGeAlD
Dasatinib—ABCB1—trachea—larynx cancer	0.00119	0.00119	CbGeAlD
Dasatinib—ABCG2—lymph node—larynx cancer	0.00119	0.00119	CbGeAlD
Dasatinib—CYP1A1—lymph node—larynx cancer	0.00113	0.00113	CbGeAlD
Dasatinib—ABCB1—thyroid gland—larynx cancer	0.000944	0.000944	CbGeAlD
Dasatinib—ABCB1—lymph node—larynx cancer	0.000587	0.000587	CbGeAlD
